Home/Akribes Biomedical/Dr. Barbara Wolff-Winiski, MBA
DB

Dr. Barbara Wolff-Winiski, MBA

Co-Founder, CEO & CSO

Akribes Biomedical

Therapeutic Areas

Akribes Biomedical Pipeline

DrugIndicationPhase
AKR101Chronic Wounds (e.g., venous leg ulcers, diabetic foot ulcers)Pre-clinical